Literature DB >> 10794356

Efficient mutation detection in mismatch repair genes using a combination of single-strand conformational polymorphism and heteroduplex analysis at a controlled temperature.

F P Wikman1, N Katballe, M Christensen, S Laurberg, T F Orntoft.   

Abstract

Single-strand conformational polymorphism analysis (SSCP) and heteroduplex analysis (HD) were tested as methods for mutation screening with respect to experimental variation, sensitivity, and specificity. Thirty-nine fluorescently labeled PCR products covering the two mismatch repair genes, hMLH1 and hMSH2, were tested in 15 patients for pattern changes, using SSCP and HD at two temperatures, in a total of 2340 runs. SSCP was most efficient in detecting base changes, whereas HD was the method of choice when detecting deletions. SSCP and HD at 20 degrees C were most effective (sensitivity 97%, specificity 49%), and SSCP and HD at 10 degrees C gave no additional information, except in one case where an exon had two base changes. Several mutations only showed a small pattern change in one of the two strands, most explicit at 20 degrees C. No correlation between the type of base change and the size or direction of the pattern changes could be found.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10794356     DOI: 10.1089/109065700316426

Source DB:  PubMed          Journal:  Genet Test        ISSN: 1090-6576


  3 in total

1.  Combined SSCP/duplex analysis by capillary electrophoresis for more efficient mutation detection.

Authors:  P Kozlowski; W J Krzyzosiak
Journal:  Nucleic Acids Res       Date:  2001-07-15       Impact factor: 16.971

2.  Frequency of hereditary non-polyposis colorectal cancer in Danish colorectal cancer patients.

Authors:  N Katballe; M Christensen; F P Wikman; T F Ørntoft; S Laurberg
Journal:  Gut       Date:  2002-01       Impact factor: 23.059

3.  Role of chance in familial aggregation of colorectal cancer.

Authors:  N Katballe; S M Bentzen; M Christensen; F P Wikman; T Ørntoft; S Laurberg
Journal:  Br J Cancer       Date:  2001-04-20       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.